Angiolife Healthcare 2020 is the name we have given to the growth strategy we have developed for the coming decade.
The ongoing changes in the pharmaceuticals industry will represent a challenge, but also provide great opportunities. Angiolife Healthcare intends to seize these opportunities by being a smart, audacious, knowledge-based and a driving player on the market.
The strategies outlined below include activities that our employees and strategic partners engage in daily basis. The work takes place in an atmosphere in which both individual and joint initiatives are actively encouraged. Simple solutions to complex problems are the cornerstone of Angiolife Healthcare business philosophy. The strategies listed below serve as guidance in the work of achieving our goals.
Angiolife Healthcare 2020 includes four ambitious goals, which form the basis for our strategies for sustainable long-term growth.
1. Increase market shares on all markets on which we currently operate and attain a top 50 position.
2. Increase market presence outside Asia and become a global company.
3. Strengthen value in the product portfolio through a well-balanced selection of licensed products and products developed in-house within the focus areas of niche, complex and strategically important products.
4. Develop and maintain a consolidated, first-class global supply chain.
Angiolife provides quality Medicines at affordable prices.
The Angiolife spirit is grounded on cost-consciousness, the willingness to assume responsibility and on innovative simplicity.
Angiolife 2020 is the name we have given to the growth strategy we have developed for the coming decade.